Merck KGaA (MKKGY)
31.18
-0.10
(-0.30%)
USD |
OTCM |
Apr 18, 10:52
Merck Debt to Equity Ratio: 0.3504 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3504 |
| September 30, 2023 | 0.3882 |
| June 30, 2023 | 0.4189 |
| March 31, 2023 | 0.4071 |
| December 31, 2022 | 0.3821 |
| September 30, 2022 | 0.391 |
| June 30, 2022 | 0.4547 |
| March 31, 2022 | 0.4639 |
| December 31, 2021 | 0.483 |
| September 30, 2021 | 0.5321 |
| June 30, 2021 | 0.6219 |
| March 31, 2021 | 0.6528 |
| December 31, 2020 | 0.6845 |
| September 30, 2020 | 0.7619 |
| June 30, 2020 | 0.7836 |
| March 31, 2020 | 0.7466 |
| December 31, 2019 | 0.7035 |
| September 30, 2019 | 0.6908 |
| June 30, 2019 | 0.6513 |
| March 31, 2019 | 0.538 |
| December 31, 2018 | 0.5172 |
| September 30, 2018 | 0.7237 |
| June 30, 2018 | 0.7687 |
| March 31, 2018 | 0.7685 |
| December 31, 2017 | 0.7646 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.8324 |
| June 30, 2017 | 0.9033 |
| March 31, 2017 | 0.8503 |
| December 31, 2016 | 0.891 |
| September 30, 2016 | 0.9763 |
| June 30, 2016 | 1.043 |
| March 31, 2016 | 1.045 |
| December 31, 2015 | 1.058 |
| September 30, 2015 | 0.7397 |
| June 30, 2015 | 0.5865 |
| March 31, 2015 | 0.5757 |
| December 31, 2014 | 0.4665 |
| September 30, 2014 | 0.3561 |
| June 30, 2014 | 0.3605 |
| March 31, 2014 | 0.3333 |
| December 31, 2013 | 0.3356 |
| September 30, 2013 | 0.358 |
| June 30, 2013 | 0.4427 |
| March 31, 2013 | 0.4272 |
| December 31, 2012 | 0.4298 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.508 |
| September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3504
Minimum
Dec 2023
0.7836
Maximum
Jun 2020
0.5562
Average
0.5321
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| Affimed NV | 0.2102 |
| InflaRx NV | 0.00 |
| MorphoSys AG | 12.71 |
| BioNTech SE | 0.0108 |
| Immatics NV | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 53.61B |
| Total Liabilities (Quarterly) | 24.03B |
| Shareholders Equity (Quarterly) | 29.49B |
| Current Ratio | 1.425 |
| Net Debt Paydown Yield | 0.15% |